India targets hepatitis B and C elimination by 2030

India is accelerating its public health agenda to eliminate hepatitis B and C infections by 2030, building on existing surveillance and treatment infrastructure across the country. The comprehensive approach addresses all stages of disease management, from prevention and early detection to treatment and long-term patient care, aiming to reduce disease burden significantly.

The elimination strategy encompasses widespread screening programmes to identify infected individuals in both urban and rural populations. Enhanced diagnostic capabilities and accessibility to testing services form a cornerstone of the initiative, enabling early case detection and intervention before complications develop.

Prevention remains a critical pillar, with expanded immunisation programmes for hepatitis B and public awareness campaigns designed to reduce transmission routes. The plan integrates treatment protocols to ensure diagnosed patients receive timely and effective care, while strengthening support systems for disease management and monitoring.

India's commitment aligns with global health objectives to control viral hepatitis as a public health priority. The multisectoral approach involves coordination between health authorities, medical professionals and community organisations to implement the elimination roadmap systematically across all states and union territories.

Successful execution of the strategy is expected to substantially reduce hepatitis-related mortality and morbidity while preventing new infections through a combination of clinical interventions and public health measures.